Fig. 7
Regulation of CXE-NLC in eicosanoid-associated proteins and MAPK pathways. (A) Relative band intensity and western blot analysis of eicosanoids (COXs and cPLA2). (B) Relative band intensity and western blot analysis of MAPKs (p38, ERK, and JNK). Nor: untreated; Ctrl: carrageenan-treated control; Glu: L-glutamine, 250 mg/kg BW; CXE: free CXE, 200 mg/kg BW; NLC: blank NLC; CXE-NLC: NLCs at dosages of CXE 50, 100, and 200 mg/kg BW. Data are expressed as the mean ± SD (n = 3). Different letters (a–g) indicate statistically significant differences (p < 0.05) among all groups.
